BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:picankibart readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of picankibart\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07552454-39@assetmemo.bio
DTSTAMP:20261121T005606Z
DTSTART;VALUE=DATE:20271015
DTEND;VALUE=DATE:20271016
SUMMARY:picankibart: Phase na readout est. (NCT07552454)
DESCRIPTION:picankibart\, phase na.\nStudy: Picankibart in Palmoplantar Pus
 tulosis\nEstimated primary completion: 15 October 2027. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/picankibart#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07552454
URL:https://assetmemo.bio/drug/picankibart#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07295509-39@assetmemo.bio
DTSTAMP:20261121T005606Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:picankibart: Phase 2/3 readout est. (NCT07295509)
DESCRIPTION:picankibart\, phase 2/3.\nStudy: A Study of Picankibart in Pati
 ents With Active Psoriatic Arthritis\nEstimated primary completion: 31 Dec
 ember 2029. This is a ClinicalTrials.gov estimate\, not a confirmed readou
 t date\, and it can move.\nDrug page: https://assetmemo.bio/drug/picankiba
 rt#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0
 7295509
URL:https://assetmemo.bio/drug/picankibart#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
